A carregar...

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6–35 Months: A Randomized, Controlled Trial

BACKGROUND. Improved influenza vaccine strategies for infants and preschool children are a high priority. METHODS. The immunological response and safety of a thimerosal-free trivalent inactivated influenza vaccine at 2 different doses (0.50 mL vs 0.25 mL) was evaluated in children aged 6–35 months....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Langley, Joanne M., Vanderkooi, Otto G., Garfield, Hartley A., Hebert, Jacques, Chandrasekaran, Vijayalakshmi, Jain, Varsha K., Fries, Louis
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3656551/
https://ncbi.nlm.nih.gov/pubmed/23687572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jpids/pis012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!